Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Last 

Alabama

Research Site
Birmingham Alabama 35233
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Mobile Alabama 36604
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Alaska

Research Site
Anchorage Alaska 99508
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Arizona

Research Site
Gilbert Arizona 85234
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Peoria Arizona 85381
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Phoenix Arizona 85016
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Phoenix Arizona 85013
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

View More »

St. Joseph's Hospital and Medical Center
Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Scottsdale Arizona

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Research Site
Tucson Arizona 85704
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Tucson Arizona 85710
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

California

Research Site
Berkeley California 94704
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Burbank California 91505
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Providence Saint Joseph Medical Center
Burbank California 91505

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Research Site
Concord California 94520
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

John Muir Medical Center-Concord Campus
Concord California 94520

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

View More »

Research Site
Corona California 92879
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
La Jolla California 92093-0957
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

La Jolla California

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Research Site
Long Beach California 90806
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Long Beach Memorial Medical Center
Long Beach California 90806

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Research Site
Los Angeles California 90027
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Los Angeles California

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Research Site
Los Angeles California 90027

Patients are needed to participate in a clinical research study evaluating AMG386 plus PLD and Placebo plus PLD for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cancer

Research Site
Orange California 92868
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Oxnard California 93030
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Rancho Mirage California 92270
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Research Site
Sacramento California 95816
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

University of California At San Diego
San Diego California 92103

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

San Francisco California

A clinical trial to evaluate treatments using INCB024360 and tamoxifen for patients with Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Research Site
San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating AMG386 plus PLD and Placebo plus PLD for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cancer

Colorado

Research Site
Aurora Colorado 80045
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora Colorado 80045

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

University of Colorado Denver
Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Research Site
Englewood Colorado 80113
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Connecticut

Research Site
Bridgeport Connecticut 06606
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

University of Connecticut
Farmington Connecticut 06030

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

Research Site
Hartford Connecticut 06106
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Hartford Hospital
Hartford Connecticut 06102

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

Saint Francis Hospital and Medical Center
Hartford Connecticut 06105

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

View More »

Hartford Hospital
Hartford Connecticut 06102

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

St. Francis Hospital and Medical Center
Hartford Connecticut 06105

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Research Site
New Britain Connecticut 06050
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

The Hospital of Central Connecticut
New Britain Connecticut 06050

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

The Hospital of Central Connecticut
New Britain Connecticut 06050

Patients are needed to participate in a clinical research study evaluating pegylated liposomal doxorubicin (PLD), VTX-2337 and Placebo for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Research Site
Norwalk Connecticut 06856

Patients are needed to participate in a clinical research study evaluating AMG386 plus PLD and Placebo plus PLD for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cancer

Research Site
Stamford Connecticut 06902
Updated

A clinical research study of AMG 386, Paclitaxel, AMG 386 Placebo and Carboplatin for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cancer

Delaware

Beebe Medical Center
Lewes Delaware 19958

A Phase 2 clinical study for patients with Fallopian Tube Cancer, Ovarian Cancer or Primary Peritoneal Cavity Cancer

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Last